WEKO3
アイテム
Correlation of epidermal growth factor receptor mutation status and PD-L1 expression with [18F]FDG PET using volume-based parameters in non-small cell lung cancer
https://kagawa-u.repo.nii.ac.jp/records/2000852
https://kagawa-u.repo.nii.ac.jp/records/2000852c51ff761-1f84-4b65-84e0-abdd735cb9b7
名前 / ファイル | ライセンス | アクション |
---|---|---|
![]() |
|
|
![]() |
|
|
![]() |
|
Item type | 学位論文 / Thesis or Dissertation(1) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
公開日 | 2025-04-09 | |||||||||||||
タイトル | ||||||||||||||
タイトル | Correlation of epidermal growth factor receptor mutation status and PD-L1 expression with [18F]FDG PET using volume-based parameters in non-small cell lung cancer | |||||||||||||
言語 | en | |||||||||||||
言語 | ||||||||||||||
言語 | eng | |||||||||||||
資源タイプ | ||||||||||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_db06 | |||||||||||||
資源タイプ | doctoral thesis | |||||||||||||
アクセス権 | ||||||||||||||
アクセス権 | open access | |||||||||||||
アクセス権URI | http://purl.org/coar/access_right/c_abf2 | |||||||||||||
著者 |
石村, 茉莉子
× 石村, 茉莉子
|
|||||||||||||
抄録 | ||||||||||||||
内容記述タイプ | Abstract | |||||||||||||
内容記述 | Objective: We investigated the relationship between 2-deoxy-2-[18F]fluoro-D-glucose (FDG) PET using volume-based parameters and epidermal growth factor receptor (EGFR) mutation status, programmed death-ligand-1 (PD-L1) expression level, and their combination, in pretreated non-small cell lung cancer (NSCLC). | |||||||||||||
言語 | en | |||||||||||||
抄録 | ||||||||||||||
内容記述タイプ | Abstract | |||||||||||||
内容記述 | Methods: FDG PET findings and EGFR mutation status and PD-L1 expression level were investigated retrospectively in 93 patients with newly diagnosed NSCLC (77 adenocarcinomas, 16 squamous cell carcinomas). Tumors were divided into six groups: EGFR mutant/negative PD-L1, EGFR mutant/low PD-L1, EGFR mutant/high PD-L1, EGFR wild/negative PD-L1, EGFR wild/low PD-L1, and EGFR wild/high PD-L1. The maximum standardized uptake value (SUVmax), metabolic tumor volume (MTV), and total lesion glycolysis (TLG) for primary tumor were measured from PET images. The EGFR mutation status and PD-L1 expression level were estimated in tumor tissue specimens and compared with the PET parameters. | |||||||||||||
言語 | en | |||||||||||||
抄録 | ||||||||||||||
内容記述タイプ | Abstract | |||||||||||||
内容記述 | Results: None of the PET parameters differed significantly between EGFR-mutated and wild-type EGFR. According to the PD-L1 level, significant differences were detected in SUVmax (P = 0.001) and TLG (P = 0.016), but not MTV. Comparing all six groups, significant difference was detected in only SUVmax (P = 0.011). | |||||||||||||
言語 | en | |||||||||||||
抄録 | ||||||||||||||
内容記述タイプ | Abstract | |||||||||||||
内容記述 | Conclusion: Based on the preliminary results of this study, FDG PET may help in the prediction of PD-L1 expression level, but not EGFR mutation status, in patients with newly diagnosed NSCLC. The SUVmax rather than MTV or TLG, may be of value in predicting the six groups according to the combination of EGFR mutation status and PD-L1 expression level. | |||||||||||||
言語 | en | |||||||||||||
学位名 | ||||||||||||||
言語 | ja | |||||||||||||
学位名 | 博士(医学) | |||||||||||||
学位授与機関 | ||||||||||||||
識別子Scheme | kakenhi | |||||||||||||
識別子 | 16201 | |||||||||||||
言語 | ja | |||||||||||||
機関名 | 香川大学 | |||||||||||||
言語 | en | |||||||||||||
機関名 | Kagawa University | |||||||||||||
学位授与年月日 | ||||||||||||||
学位授与年月日 | 2025-03-04 | |||||||||||||
学位授与番号 | ||||||||||||||
学位授与番号 | 乙第302号 | |||||||||||||
権利 | ||||||||||||||
言語 | en | |||||||||||||
権利情報 | Copyrightc 2021 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited. | |||||||||||||
権利 | ||||||||||||||
言語 | en | |||||||||||||
権利情報Resource | https://creativecommons.org/licenses/by-nc-nd/4.0/ | |||||||||||||
item_10006_relation_22 | ||||||||||||||
関連タイプ | isReferencedBy | |||||||||||||
識別子タイプ | URI | |||||||||||||
関連識別子 | https://pubmed.ncbi.nlm.nih.gov/34908022/ | |||||||||||||
関連サイト | ||||||||||||||
関連タイプ | isVersionOf | |||||||||||||
識別子タイプ | DOI | |||||||||||||
関連識別子 | https://doi.org/10.1097/mnm.0000000000001517 | |||||||||||||
出版タイプ | ||||||||||||||
出版タイプ | P | |||||||||||||
出版タイプResource | http://purl.org/coar/version/c_fa2ee174bc00049f | |||||||||||||
キーワード | ||||||||||||||
言語 | en | |||||||||||||
主題Scheme | Other | |||||||||||||
主題 | epidermal growth factor receptor | |||||||||||||
キーワード | ||||||||||||||
言語 | en | |||||||||||||
主題Scheme | Other | |||||||||||||
主題 | 18F-FDG | |||||||||||||
キーワード | ||||||||||||||
言語 | en | |||||||||||||
主題Scheme | Other | |||||||||||||
主題 | PET | |||||||||||||
キーワード | ||||||||||||||
言語 | en | |||||||||||||
主題Scheme | Other | |||||||||||||
主題 | programmed death-ligand-1 |